Cargando…
Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin(®)) for AMD followed by controlateral sympathetic ophthalmia
PURPOSE: To report a severe ocular complication initiated ten days after intravitreal administration of bevacizumab (Avastin(®)), in a patient with exudative age-related macular degeneration (AMD). PATIENTS AND METHOD: Case report. RESULTS: Ten days after intravitreal injection of 1.25 mg Avastin(®)...
Autores principales: | Brouzas, Dimitrios, Koutsandrea, Chryssanthi, Moschos, Marilita, Papadimitriou, Spiros, Ladas, Ioannis, Apostolopoulos, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732055/ https://www.ncbi.nlm.nih.gov/pubmed/19714263 |
Ejemplares similares
-
Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009) -
Metastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleation
por: Koutsandrea, Chryssanthi, et al.
Publicado: (2008) -
Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
por: Ladas, Ioannis D, et al.
Publicado: (2009) -
Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma
por: Mandal, Subrata, et al.
Publicado: (2011) -
Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks
por: Sachdev, Nishant, et al.
Publicado: (2007)